Neurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 ...

They then tested the effects of Congo red in the R62 model of Huntington's chorea and found that it induced the clearance of aggregates and improved survival, weight loss and motor function.